Journal of labelled compounds and radiopharmaceuticals p. 425 - 433 (1996)
Update date:2022-08-02
Topics:
Gong, Leyi
Pames, Howard
The preparation of the title compound, a selective 5-HT3 antagonist with anti-emetic properties, is described. The key intermediate involved is 6-bromo-1,2-dihydronaphthoid acid (5), which was synthesized from 4-bromophenylacetic acid by Micheal addition, acid-induced ring cyclization, reduction and dehydration. Compound (5) was selected because it has two labelling sites to ensure high specific activity of the final product. Reduction of amide 6 with carrier-free tritium gas, followed by reduction of the amide functional group with BF3-OEt2 and intramolecular cyclization furnished the title compound having a specific activity of 70.4 Ci/mmol and >99% purity.
View MoreTianjin Te-An Chemtech Co., Ltd.(expird)
Contact:+86-22-65378638
Address:A5-8, No.80 Haiyun Street, TEDA
HENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Contact:17316303296
Address:240 Amboy Ave
Beyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
SuZhou Bichal Biological Technology CO.,LTD
Contact:+86-512-68051130
Address:NO.32 huoju road HI-TECH Industrial development zone SuZhou China
Doi:10.1021/acs.jmedchem.9b01649
(2019)Doi:10.1016/j.bmcl.2010.08.043
(2010)Doi:10.1002/hlca.19960790321
(1996)Doi:10.1016/j.jorganchem.2007.11.023
(2008)Doi:10.1021/acsmedchemlett.5b00102
(2015)Doi:10.1016/0040-4020(96)00258-X
(1996)